Biofrontera reports earnings results for the third quarter and first nine months of 2018 Leverkusen, Germany, Nov. 16, 2018 (GLOBE NEWSWIRE) -- Biofrontera AG (NASDAQ: BFRA; Frankfurt Stock Exchange: B8F) (the “Company”), an international biopharmaceutical company, today reported its...

Biofrontera Announces Conference Call to Discuss Q3 2018 Financial Results Leverkusen, Germany, Nov. 05, 2018 (GLOBE NEWSWIRE) -- Biofrontera AG (NASDAQ: BFRA; Frankfurt Stock Exchange: B8F) (the “Company”), an international biopharmaceutical company, will be releasing its...

Correction of news release from August 31, 2018: Biofrontera reports significant revenue growth for the first 6 months of 2018 Leverkusen, Germany, Sept. 03, 2018 (GLOBE NEWSWIRE) -- Biofrontera AG (NASDAQ: BFRA; Frankfurt Stock Exchange: B8F) (the “Company”), an international biopharmaceutical company, today reported...

Newport Beach Dermatologist Shares Advice for Most Common Form of Skin Cancer NEWPORT BEACH, CA--(Marketwired - Mar 25, 2014) - As the most frequently occurring form of all cancers (according to the Skin Cancer Foundation), basal cell carcinoma is a type of nonmelanoma skin...